BIOMAT Database Logo BIOMAT Database Logo

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. 1993

U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
Max-Planck-Gesellschaft, Arbeitsgruppe Immunologie, Universität Erlangen, Germany.

X chromosome-linked immunodeficiency with hyper-IgM (HIGM1, MIM number 308230) is a rare disorder characterized by recurrent bacterial infections, very low or absent IgG, IgA and IgE, and normal to increased IgM and IgD serum levels. HIGM1 has been suggested to result from ineffective T-cell help for B cells. We and others have identified a novel, TNF-related activation protein (TRAP) that is exclusively expressed on the surface of stimulated T cells. TRAP, a type II transmembrane protein of M(r) 33,000, is the physiological ligand for CD40 (refs 5-8). Crosslinking of CD40 on B cells induces, in the presence of lymphokines, immunoglobulin class switching from IgM to IgG, IgA or IgE. Mapping of the TRAP gene to the X-chromosomal location q26.3-q27.1 (ref. 6) suggested a causal relationship to HIGM1, which had previously been assigned to Xq26 (refs 12-14). Here we present evidence that point mutations in the TRAP gene give rise to nonfunctional or defective expression of TRAP on the surface of T cells in patients with HIGM1. The resultant failure of TRAP to interact with CD40 on functionally intact B cells is responsible for the observed immunoglobulin isotype defect in HIGM1.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".
April 1994, Immunological reviews,
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
February 1993, Nature,
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
January 1993, Cell,
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand.
April 1999, The Journal of biological chemistry,
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
CD40 ligand and its role in X-linked hyper-IgM syndrome.
November 1993, Immunology today,
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.
February 1993, Science (New York, N.Y.),
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.
October 2011, Blood,
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.
October 1998, Blood,
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.
August 2000, Clinical and experimental immunology,
U Korthäuer, and D Graf, and H W Mages, and F Brière, and M Padayachee, and S Malcolm, and A G Ugazio, and L D Notarangelo, and R J Levinsky, and R A Kroczek
X-linked immunodeficiency with hyper-IgM (XHIM).
June 2000, Clinical and experimental immunology,
Copied contents to your clipboard!